A detailed history of Point72 (Difc) LTD transactions in Immuneering Corp stock. As of the latest transaction made, Point72 (Difc) LTD holds 16 shares of IMRX stock, worth $32. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 4,983 99.68%
Holding current value
$32
Previous $6.38 Million 99.37%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.03 - $3.21 $5,116 - $15,944
-4,967 Reduced 99.68%
16 $40,000
Q2 2024

Aug 14, 2024

BUY
$1.28 - $2.75 $6,378 - $13,703
4,983 New
4,983 $6.38 Million

Others Institutions Holding IMRX

About Immuneering Corp


  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $53.8M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.